Shares of Valeant (VRX -2.3%) hit some volatility this morning after its 2012 guidance...

|About: Valeant Pharmaceuticals Int... (VRX)|By:, SA News Editor

Shares of Valeant (VRX -2.3%) hit some volatility this morning after its 2012 guidance presentation. The company sees Q4 earnings in the mid-range of estimates, while it ups 2012 EPS estimates to between $3.95 - $4.20. More importantly, the company says there's still no agreement on the buyout process or price with Ista Pharmaceuticals (ISTA -0.4%), following Ista's rejection of its recent bid in December, and puts a drop dead date of January 31 for negotiations.